期刊文献+

血清胆固醇水平在妊娠合并重型肝炎预后判断中的临床意义 被引量:5

Clinical Significance of Serum Cholesterol in Predicting the Prognosis of Pregnancy Complicating Hepatitis Gravis
下载PDF
导出
摘要 【目的】探讨血清胆固醇水平(CHOL)在妊娠合并重型肝炎预后判断中的临床意义。【方法】收集40例在我院治疗的妊娠合并重型肝炎患者的临床资料,按其预后分为存活组(22例)及死亡组(18例),回顾性分析CHOL与病情变化及预后的关系。【结果】妊娠合并重型肝炎存活组与死亡组的CHOL差异有统计学意义。CHOL≤1.6mmol/L、CHOL进行性下降或凝血酶原活动度(PTA)≤30%的同时CHOL≤2.0mmol/L,病死率高。CHOL与PTA间存在正相关(r=0.369)。【结论】CHOL可作为妊娠合并重型肝炎预后判断的临床联合指标之一,CHOL≤1.6mmol/L、CHOL进行性下降、PTA≤30%的同时CHOL≤2.0mmol/L,均提示预后不良。 [Objective] To investigate the clinical significance of serum cholesterol in predicting the prognosis of pregnancy complicating hepatitis gravis. [Methods] Clinical data of 40 patients with pregnancy complicating hepatitis gravis for hospitalization were collected, difference of CHOL between survival group and dead group and the relationship between CHOL and the change of patient's condition and prognosis were analyzed retrospectively. [Results] The difference of CHOL between survival group and dead group in pregnancy complicating hepatitis gravis was significant. CHOL ≤ 1.6 mmol/L, progressive descending of CHOL, and PTA ≤ 30% complicating with CHOL ≤ 2.0 mmol/L, all mean high fatality. There was positive correlation between CHOL and PTA (r = 0.369). [Conclusions] The descending of CHOL can be one of the clinical combined indexes of judging prognosis for pregnancy complicating hepatitis gravis, CHOL ≤ 1.6 mmol/L, progressive descending of CHOL and PTA ≤ 30% complicating with CHOL ≤ 2.0 mmol/L, all predict poor prognosis.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2008年第5期595-597,共3页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省科技计划项目(2005B340201006) 广东省中医药局项目(1060166)
关键词 妊娠 重型肝炎 胆固醇 预后 pregnancy hepatitis gravis cholesterol diagnosis prognosis
  • 相关文献

参考文献12

二级参考文献20

  • 1张殿福.重型肝炎20例临床分析[J].中国全科医学,2004,7(12):915-915. 被引量:3
  • 2李玉芳,焦运,刘娅.重型肝炎预后影响因素分析及评分评估[J].中西医结合肝病杂志,2004,14(5):303-304. 被引量:8
  • 3金振锋 朱雅琪.消化内科-主治医生 第1版[M].北京:北京医科大学,中国协和医科大学联合出版社,1998.225-243.
  • 4邹正升 陈菊妹 辛绍杰.慢性重型病毒性肝炎发病特点的探讨[J].临床肝胆病杂志,2001,17:111-111.
  • 5顾长海.重型肝炎的诊断应与国际接轨[J].中华肝脏病杂志,2000,8(4):307-307.
  • 6Acharya SK,Dasarathy S,Kumer TL,etal. Fulminant hepatitis in a tropical population: clinical course,cause,and earlypredictors of outcome.Hepatology,1996,23:1448-1455.
  • 7Kondo M,Hada T,Fukui K,et al. Enzyme-linked immunosorbent assay(ELISA) for Aleuriaaurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronichepatitis. Clin Chim Acta,1995,243:1-9.
  • 8Huo TI,Wu JC,Sheng WY,et al.Prognostic factor analysis of fulminant andsubfulminant hepatic failure in an area endemic for hepatitis B.J GastroenterolHepatol,1996,11:560-565.
  • 9邱谷香,马为民,周伯平.慢性重型肝炎转归因素的分析[J].临床医学,1999,19(3):19-20. 被引量:10
  • 10潘永苗,董晣岳,石一复.正常妊娠血清肝功能试验变化及意义[J].中国实用妇科与产科杂志,1999,15(9):542-544. 被引量:16

共引文献17316

同被引文献54

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部